Dividend-News

Daily dividend news for investors in dividend stocks


Gsk





Stock name Last trade   P/E Earnings/Share Dividend/Share Dividend yield
GLAXOSMITHKLINE 40.98   18.4 2.23 1.83 4.54

GLAXOSMITHKLINE - GSK  


Dividend articles featuring Glaxosmithkline (GSK):
Lanny's July Dividend Income Summary
Bert's July Dividend Income Summary
5%+ Dividend Yield Portfolio: Grinding Along In 2019 (July 2019 Review)
5%+ Dividend Yield Portfolio: Coping With Existential Dread (May 2019 Review)
5%+ Dividend Yield Portfolio: The Number Of Stocks To Own (Apr 2019 Review)
Sector Study: Healthcare Vs. Technology Dividend Dogs, Which To Buy?
Parking Cash In The Large Cap 5% Dividend Club
Lanny's January Dividend Income Summary
5%+ Dividend Yield Portfolio: Profiting Handsomely From Volatility (Jan 2019 Review)
High Yield Stocks For Investors Looking For Income Options
5%+ Dividend Yield Portfolio: Beating The Market 2 Of The Last 3 Years (December 2018 Review)
5%+ Dividend Yield Portfolio: Profiting From A Return To Normal (October 2018 Review)
Healthcare Yields Of 3% To 4.8% From Top 10 WallStars In November
Bert's October Dividend Income Summary
5%+ Dividend Yield Portfolio: Playing Offense, Not Running Scared (October 2018 Review)
5%+ Dividend Yield Portfolio: Ignore The Political Circus (Sep 2018 Review)
First Quarterly Update - Steve's Dividend Portfolio And Strategy For Replacing My Salary With Dividend Income
5%+ Dividend Yield Portfolio: Foreign Markets Disappointing You Again? (August 2018 Review)
5%+ Dividend Yield Portfolio: Sticking To The Plan (July 2018 Review)
GlaxoSmithKline: Dividend Safe For Now
4 Safe Blue Chips With 5%+ Dividend Yields
59 Top-Yield Healthcare Equities For June
GlaxoSmithKline Combines Dividend With Growth Potential
Lanny's April Dividend Income Summary
50 Healthcare Top Yield Equities For April
5%+ Dividend Yield Portfolio: Bought The Dip (Feb. 2018 Review)
Lanny's January Dividend Income Summary
5%+ Dividend Yield Portfolio: The Rising Tide Raises My Boat (Jan 2018 Review)
Stocks For 2018: Beaten Down, With Dividends, And Recession Resistant
5%+ Dividend Yield Portfolio: Meeting Return Goals And Surviving FOMO (Dec 2017 Review)
'Safer' Dividend Healthcare Gainers Glaxo, Pfizer & Medical Facilities Are Tagged Tops By Broker Targets For...
Sure-Thing Dividends Can Brighten Your Retirement Picture
FTSE 100 Defensive Dividend Stocks Secretly Undergoing Corrections
GlaxoSmithKline: Dividend Risk Brings Opportunity
5%+ Dividend Yield Portfolio: Risk-On Rally Continues (Nov 2017 Review)
'Safer' Dividend Follower Favorites Leader Is Spark Energy, As Per November Gains
Followers Find Frontier Tops By Broker Target Gains & Yield For November
Glaxo And Pfizer Are Top 'Safer' Dividend Healthcare Gainers For November
2 High Quality U.K. Dividend Stocks For Your Portfolio.
5%+ Dividend Yield Portfolio: Growth Outpaces Value (Oct 2017 Review)
GlaxoSmithKline: A Comparative Analysis Of Potential Takeover Targets, Cash Flow And Dividend
Only 16 Of 61 Are 'Safer' Dividend Healthcare Dogs For October
5%+ Dividend Yield Portfolio: Real Estate As A Value Diversification (Sep 2017 Review)
GlaxoSmithKline: Get Ready For A Dividend Cut By This Pharma Giant
'Safer' Dividend Follower Favorites And Rogues Led By Capitala Finance
Risk-Tolerant Healthcare Investors Should Look To Pharmaceutical Stocks For Dividend Income
GlaxoSmithKline Dividends Look More Attractive With New Management At The Helm
'Safer' Dividend Follower Favorites And Rogues Led By RAIT Financial & Chico, Per August Gain Estimates
HealthSouth Invades Big Pharma Duet To Place Atop 'Safer' Dividend Healthcare Pack For Gains In August
Lanny's July Dividend Income Summary
'Safer' Dividend Big-Gain Healthcare Dog Leads 3 Big Pharma Names In June
5%+ Dividend Yield Portfolio: It Ain't About Investing Sexy, It's About Investing For The Long Haul (May 2017...
'Safer' Dividend Healthcare Dog's 55% Top Gain Equals Sum Of Four Tailing It In May
Lanny's April Dividend Income Summary
Bert's April Dividend Income Summary
5%+ Dividend Yield Portfolio: Growth Stocks Have Momentum, But Dividends Are Slow And Steady (April 2017...
Healthcare Dogs See Medical Care Tops By Yield But Big Pharma Tops By Gains For April
GlaxoSmithKline: A High Yield, But A Lot Of Risks To Consider
The Most Popular European Dividend Stocks
5%+ Dividend Yield Portfolio: New Rules For FOMO (February 2017 Review)
Lanny's January Dividend Income Summary
5%+ Dividend Yield Portfolio: Taking Profits As Market Valuations Flash Warnings (Jan 2017 Review)
Bert's January Dividend Income Summary
3 Stocks Offering Yields To Help Retirees Pay Current Bills
BP: Asset Sales, New Projects Fuel Its 6.7% Dividend Yield
GlaxoSmithKline: Robust Pipeline Supports Its 5.5% Dividend Yield
Lanny's October Dividend Income Summary
Bert's October Dividend Income Summary
5%+ Dividend Yield Portfolio: Nearly Doubling The S&P 500 Return In 2016 (October 2016 Review)
My Third Quarter Portfolio Review - Focus On Dividend Growth And Quality
5%+ Dividend Yield Portfolio: Churning Out Wins (Sep 2016 Review)
A Unique Method To Value Dividend Stocks Based On Expected Growth
5%+ Dividend Yield Portfolio: Outperformance Continues (Aug 2016 Review)
Eleven Morningstar Sector Dogs Led By Financial Yields In August
A New Low Volatile International ETF For Dividend Lovers
Dividend Health Checkup Podcast - Episode 45 With Guest John Kingham (Part 1)
Bert's July Dividend Income Summary
Lanny's July Dividend Income Summary
Retirement Strategy: 5 Pharmaceutical Dividends To Buy Here
Big Pharma Dominates Healthcare But Caregivers Are Top Sector Yield Dogs In July
11 Morningstar Sector Leaders Show REITs Tops By Yield In July
Beware Of Dividend Traps In The Rush For Large-Cap Safety
Ignoring The Lions, Tigers, And Brexits And Focusing On Alpha - 5%+ Dividend Yield Portfolio (A June 2016...
5%+ Dividend Yield Portfolio - Positioning For Volatility (A May 2016 Review)
GlaxoSmithKline: A Cash Flow Caution To Dividend Investors?
Lanny's April Dividend Income Summary
5%+ Dividend Yield Portfolio - 10% Returns For March/April 2016
Bert's April Dividend Income Summary
Followers Favor Monthly Pay Dividend Dogs In April Survey
At The Dividend Dance Its Time To Change Partners - Buy Old Biotech, Sell Utilities
Winning In 2016: A 5%+ Dividend Yield Portfolio - Outlook, Performance And Trades For February 2016
How To Maximize Dividends And Create A Winning Income Portfolio In 2016
Biotech Health Dogs Lead On 8% Yield, 90% Upside, And 91% Gain In February
GlaxoSmithKline: A Global Healthcare Company With Great Credentials And A Good Dividend
Is GlaxoSmithKline's 6% Dividend Sustainable?
Will Dividend Stocks Save You In A Bear Market?
These O'Shares ETFs Focus On Quality European Dividends
Health Lead Dog Casts 18% Yield, Large Upside
GlaxoSmithKline - Upside In The Pipeline But Some Risk To The Dividend
10 Top Healthcare Leaders Yield 3.41% To 15.58% As Of November 13